Aneurin Bevan Health Board and GlaxoSmithKline

Joint Working Agreement Executive Summary

Aneurin Bevan Health Board and GlaxoSmithKline are engaged in Joint Working to enhance the management of Chronic Obstructive Pulmonary Disease (COPD) to a standard of care defined by NICE (National Institute for Health and Clinical Excellence).

Both parties have committed resources to support this project, which will run from February 2011 – March 2012

The objective of this Joint Working project is to improve quality and productivity in the management of patients with COPD within the Health Board.

It is designed to support:

• The promotion of disease prevention and the earlier identification of patients with COPD through healthcare professional education
• Accurate diagnosis and classification of disease with access to high quality information
• Prevention of COPD exacerbations through improved patient review and appropriate use of medications in line with NICE guidelines
• Improving the quality of COPD referrals to secondary care and community teams

For further information please contact

GSK UK Customer Contact Centre: +44 (0)800 221 441

UK/PPM/0028b/10

Date of preparation March 2013